<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>PREDNISOLONE SODIUM PHOSPHATE- prednisolone sodium phosphate solution/ drops </strong><br>MWI/VetOne<br></p></div>
<h1>Prednisolone Sodium Phosphate<br>Ophthalmic Solution USP, 1% (Sterile)</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_8d59fc5f-8d82-4a37-9b2d-d39db314256f"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_07c008aa-092e-49b5-8014-1d895d5f23ed"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First">Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, is a sterile solution for ophthalmic administration having the following composition:</p>
<p><span class="Bold">Each mL Contains:</span></p>
<p>ACTIVE: Prednisolone Sodium Phosphate 10 mg (1%) [equivalent to 9.1 mg/mL prednisolone phosphate] in a buffered isotonic solution containing INACTIVES: Hypromellose, Monobasic and Dibasic Sodium Phosphate, Sodium Chloride, Edetate Disodium and Purified Water. Sodium Hydroxide and/or Hydrochloric Acid may be added to adjust the pH (6.2 - 8.2).<br>PRESERVATIVE ADDED: Benzalkonium Chloride 0.01%.</p>
<p>The chemical name for prednisolone sodium phosphate is Pregna-1, 4-diene - 3, 20-dione, 11, 17-dihydroxy-21-(phosphonooxy)-, disodium salt, (11 β) -, which has the following structural formula:</p>
<div class="Figure"><img alt="Prednisolone Sodium Phosphate (structural formula)" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dbcab023-8a71-4c66-ac6b-b98b20a493f9&amp;name=dbcab023-8a71-4c66-ac6b-b98b20a493f9-01.jpg"></div>
<p>Molecular formula: C<span class="Sub">21</span>H<span class="Sub">27</span>Na<span class="Sub">2</span>O<span class="Sub">8</span>P</p>
<p>Molecular Weight: 484.39</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_61ca6f04-2fec-4605-a08e-23e40976e84e"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First">Prednisolone sodium phosphate causes inhibition of inflammatory response to inciting agents of mechanical, chemical, or immunological nature. No generally accepted explanation of this steroid property has been advanced.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_4d90dc18-b5c9-44e3-8c92-8302de59bf3a"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">Prednisolone Sodium Phosphate Ophthalmic Solution 1% or 1/8% is for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as <span class="product-label-link" type="condition" conceptid="374959" conceptname="Contact blepharoconjunctivitis">allergic conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> <span class="product-label-link" type="condition" conceptid="136773" conceptname="Rosacea">rosacea</span>, <span class="product-label-link" type="condition" conceptid="375265" conceptname="Punctate keratitis">superficial punctate keratitis</span>, <span class="product-label-link" type="condition" conceptid="443943" conceptname="Herpes zoster">herpes zoster</span> <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>, <span class="product-label-link" type="condition" conceptid="4274964" conceptname="Iritis">iritis</span>, cyclitis, selected infective <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span> when the inherent hazard of steroid use is accepted to obtain an advisable diminution in <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> and <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span>, corneal injury from chemical, radiation, or <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">thermal burns</span>, or penetration of foreign bodies.</p>
<p>Prednisolone Sodium Phosphate Ophthalmic Solution, 1%, is recommended for moderate to severe <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammations</span>, particularly when unusually rapid control is desired. In stubborn cases of anterior segment eye disease, systemic adrenocortical hormone therapy may be required. When deeper ocular structures are involved, systemic therapy is necessary.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_e63fe78d-bb04-4208-81ef-79d9ef31f2a3"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">The use of this preparation is contraindicated in the presence of:</p>
<p>1] Acute superficial <span class="product-label-link" type="condition" conceptid="373404" conceptname="Ophthalmic herpes simplex">herpes simplex keratitis</span>.</p>
<p>2] Fungal diseases of ocular structures.</p>
<p>3] Acute infectious stages of <span class="product-label-link" type="condition" conceptid="140633" conceptname="Vaccinia">vaccinia</span>, <span class="product-label-link" type="condition" conceptid="434272" conceptname="Varicella">varicella</span> and most other viral diseases of the cornea and conjunctiva.</p>
<p>4] <span class="product-label-link" type="condition" conceptid="434557" conceptname="Tuberculosis">Tuberculosis</span> of the eye.</p>
<p>5] <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to a component of this medication.</p>
<p>The use of this preparation is always contraindicated after uncomplicated removal of a superficial corneal foreign body.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_4e1e773d-556d-4e48-8390-022839c83c28"></a><a name="section-6"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First">NOT FOR INJECTION INTO EYE - FOR TOPICAL USE ONLY</p>
<p>Employment of steroid medication in the treatment of <span class="product-label-link" type="condition" conceptid="373404" conceptname="Ophthalmic herpes simplex">herpes simplex keratitis</span> involving the stroma requires great caution; frequent slit-lamp microscopy is mandatory.</p>
<p>Prolonged use may result in elevated intraocular pressure and/or <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, damage to the optic nerve, defects in visual acuity and fields of vision, <span class="product-label-link" type="condition" conceptid="375256" conceptname="Anterior subcapsular polar senile cataract">posterior subcapsular cataract</span> formation, or may aid in the establishment of secondary ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> from pathogens liberated from ocular tissues. In those diseases causing thinning of the cornea or sclera, perforation has been known to occur with the use of topical steroids. Acute purulent untreated <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> of the eye may be masked or activity enhanced by presence of steroid medication. Viral, bacterial, and <span class="product-label-link" type="condition" conceptid="432248" conceptname="Opportunistic mycosis">fungal infections</span> of the cornea may be exacerbated by the application of steroids.</p>
<p>This drug is not effective in mustard gas <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span> and Sjögren’s keratoconjuncitivitis.</p>
<p>If irritation persists or develops, the patient should be advised to discontinue use and consult prescribing physician.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_d9b945f5-5975-4f8b-b8b2-5add7a6960f3"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_09f68fc9-46ba-4a10-b92d-4062e7dfe2f3"></a><a name="section-7.1"></a><p></p>
<h2>General:</h2>
<p class="First">As <span class="product-label-link" type="condition" conceptid="432248" conceptname="Opportunistic mycosis">fungal infections</span> of the cornea are particularly prone to develop coincidentally with long-term steroid applications, fungus invasion must be suspected in any persistent <span class="product-label-link" type="condition" conceptid="373202" conceptname="Corneal ulcer">corneal ulceration</span> where a steroid has been used or is in use.</p>
<p>Intraocular pressure should be checked frequently.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_2e45a784-f27b-4eb6-8986-4910b3b6a7a5"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients:</h2>
<p class="First">Do not touch dropper tip to any surface as this may contaminate the solution.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_c25f396d-a289-4ec2-acbd-d5d726b263fc"></a><a name="section-7.3"></a><p></p>
<h2>Usage in Pregnancy:</h2>
<p class="First">Pregnancy Category C: Animal reproductive studies have not been conducted with prednisolone sodium phosphate. It is also not known whether prednisolone sodium phosphate can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Prednisolone sodium phosphate should be given to a pregnant woman only if clearly needed.</p>
<p>The effect of prednisolone sodium phosphate on the later growth, development and functional maturation of the child is unknown.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_69446ff5-3b6a-4848-92e8-226e3b070e41"></a><a name="section-7.4"></a><p></p>
<h2>Nursing Mothers:</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when prednisolone sodium phosphate is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_716fd3c0-e4f6-488d-82da-a62f49775a60"></a><a name="section-7.5"></a><p></p>
<h2>Pediatric Use:</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_96ad583c-aa61-47ba-8003-019e1b0d8dde"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">Glaucoma</span> with optic <span class="product-label-link" type="condition" conceptid="381732" conceptname="Nerve injury">nerve damage</span>, visual acuity and field defects, <span class="product-label-link" type="condition" conceptid="375256" conceptname="Anterior subcapsular polar senile cataract">posterior subcapsular cataract</span> formation, secondary ocular <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> from pathogens including herpes simplex and fungi, and perforation of the globe.</p>
<p>Rarely, filtering blebs have been reported when topical steroids have been used following <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">cataract</span> surgery.</p>
<p>Rarely, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, or burning may occur.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_a62b3c42-e2ed-467c-9614-d7caccb0bd09"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">Depending on the severity of <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span>, instill one or two drops of solution into the conjunctival sac up to every hour during the day and every two hours during the night as necessary as initial therapy.</p>
<p>When a favorable response is observed, reduce dosage to one drop every four hours.</p>
<p>Later, further reduction in dosage to one drop three to four times daily may suffice to control symptoms.</p>
<p>The duration of treatment will vary with the type of lesion and may extend from a few days to several weeks, according to therapeutic response. Relapses, more common in chronic active lesions than in self-limited conditions, usually respond to retreatment.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_0e7c25a3-af25-4c14-862b-9edd8d066de5"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% is supplied in a plastic squeeze bottle with a controlled drop tip in the following sizes:</p>
<p>5 mL bottle - Prod. No. 04307</p>
<p>10 mL bottle - Prod. No. 04309</p>
<p>15 mL bottle - Prod. No. 04311</p>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_storage_id_3f1b7053-67c1-4a02-89b8-7e2e98165594"></a><a name="section-10.1"></a><p></p>
<h2>Storage: </h2>
<p class="First">Store between 15° - 30° C (59° - 86° F).</p>
<p>Protect from light. Keep tightly closed.</p>
<p><span class="Underline"><span class="Bold">DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT.</span></span></p>
<p>KEEP OUT OF REACH OF CHILDREN.</p>
<p><span class="Bold">Bausch &amp; Lomb Incorporated</span><br>Tampa, FL 33637<br>©Bausch &amp; Lomb Incorporated</p>
<p>9101401 <span class="Bold">(Folded)</span><br>9101501 <span class="Bold">(Flat)</span></p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_11c972b7-ab6e-4e85-abba-568984d34d88"></a><a name="section-11"></a><p></p>
<h1>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure"><img alt="Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1% (Carton, 5 mL - MWI)" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dbcab023-8a71-4c66-ac6b-b98b20a493f9&amp;name=dbcab023-8a71-4c66-ac6b-b98b20a493f9-02.jpg"></div>
<p class="First">NDC 13985-025-02</p>
<p>Prednisolone Sodium Phosphate Ophthalmic Solution USP, 1%  </p>
<p>STERILE</p>
<p>Rx only</p>
<p>apexa</p>
<p>5mL</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PREDNISOLONE SODIUM PHOSPHATE 		
					</strong><br><span class="contentTableReg">prednisolone sodium phosphate solution/ drops</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:13985-025</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PREDNISOLONE SODIUM PHOSPHATE</strong> (PREDNISOLONE) </td>
<td class="formItem">PREDNISOLONE SODIUM PHOSPHATE</td>
<td class="formItem">10 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM PHOSPHATE, DIBASIC</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>EDETATE DISODIUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>HYPROMELLOSES</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM PHOSPHATE, MONOBASIC</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:13985-025-02</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA040070</td>
<td class="formItem">07/29/1994</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>MWI/VetOne
							(019926120)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Bausch &amp; Lomb Incorporated (196603781)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Bausch &amp; Lomb Incorporated</td>
<td class="formItem"></td>
<td class="formItem">807927397</td>
<td class="formItem">MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 11/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>dbcab023-8a71-4c66-ac6b-b98b20a493f9</div>
<div>Set id: dbcab023-8a71-4c66-ac6b-b98b20a493f9</div>
<div>Version: 1</div>
<div>Effective Time: 20101104</div>
</div>
</div> <div class="DistributorName">MWI/VetOne</div></p>
</body></html>
